Cargando...
A favorable outcome of intensive immunotherapies for new-onset refractory status epilepticus (NORSE)
BACKGROUND: New-onset refractory status epilepticus (NORSE) is a newly defined critical disease entity characterized by prolonged periods of refractory epileptic seizure with no readily identifiable cause in otherwise healthy individuals. Its etiology is uncertain, but autoimmune encephalitis is a p...
Gardado en:
| Publicado en: | J Intensive Care |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6069820/ https://ncbi.nlm.nih.gov/pubmed/30083346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-018-0315-7 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|